Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

German court suspends Resmed's patent proceedings

F&P Healthcare says German court suspends Resmed's patent proceedings

By Jonathan Underhill

Sept. 29 (BusinessDesk) - Fisher & Paykel Healthcare says the Regional Court in Munich has suspended two patent proceedings brought by rival ResMed in a tit-for-tat dispute over intellectual property for face and nasal masks.

The Auckland-based company still has two cases in progress in the court regarding the assertion of its patents against ResMed’s AirSense 10 and AirCurve 10 range of flow generator products and Lumis series of noninvasive ventilators, it said in a statement today.

Last December, F&P Healthcare succeeded in overturning the second of two preliminary injunctions against it in Germany, allowing the company to resume sales of the affected products in that country.

ResMed subsequently appealed those decisions to the Higher Regional Court in Munich. In May this year, the Higher Regional Court upheld one of the decisions of the Regional Court and ResMed withdrew its appeal of the other decision, F&P Healthcare said.

"ResMed continued the two actions on the merits with amended patent claims," it said. "However, the Regional Court in Munich has now also expressed serious doubts about the patentability of the asserted claims and has suspended the infringement cases."

Last year, ResMed filed a patent infringement complaint in the Southern District of California as well as lawsuits in Germany and New Zealand, and to the US International Trade Commission against F&P Healthcare in relation to face and nasal masks, just days after the Kiwi company filed its own patent infringement lawsuit against the US company in the US District Court for the Central District of California relating to its flow generator products and masks.

F&P Healthcare shares last traded at $12.65 and have surged 48 percent this year.

(BusinessDesk)

ends

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.